New Medications Are Needed for Children With Juvenile Idiopathic Arthritis-Reference-Cited by-同舟云学术

New Medications Are Needed for Children With Juvenile Idiopathic Arthritis

Published:2020-10-08 Issue:11 Volume:72 Page:1945-1951
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Brunner Hermine I.¹^ORCID,Schanberg Laura E.²,Kimura Yukiko³,Dennos Anne⁴,Co Dominic O.⁵,Colbert Robert A.⁶,Fuhlbrigge Robert C.⁷,Goldmuntz Ellen⁸,Kingsbury Daniel J.⁹,Patty‐Resk Cathy¹⁰,Mintz Sandra¹¹,Onel Karen¹²,Rider Lisa G.¹³^ORCID,Schneider Rayfel¹⁴,Watts Allen¹,Scheven Emily¹⁵,Lovell Daniel J.¹^ORCID,Beukelman Timothy¹⁶,

Affiliation:

1. Cincinnati Children's Hospital Medical Center Cincinnati Ohio

2. Duke Medical Center Durham North Carolina

3. Hackensack University Medical Center Hackensack New Jersey

4. Duke Center for AIDS Research Durham North Carolina

5. University of Wisconsin School of Medicine and Public Health Milwaukee

6. NIH Clinical Center Bethesda Maryland

7. Children's Hospital Colorado Aurora

8. National Institute of Allergy and Infectious Diseases, NIH Bethesda Maryland

9. Legacy Emmanuel Children's Hospital Portland Oregon

10. Children's Hospital of Michigan Detroit United States

11. Children's Hospital of Los Angeles Los Angeles California

12. Hospital for Special Surgery New York New York

13. National Institute of Environmental Health Sciences, NIH Bethesda Maryland

14. The Hospital for Sick Children Toronto Ontario Canada

15. University of California at San Francisco Medical Center

16. University of Alabama at Birmingham

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute of Environmental Health Sciences

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41390

Reference12 articles.

1. 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among C

2. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis

3. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis

4. US Food and Drug Administration.Best Pharmaceuticals for Children Act and Pediatric Research Equity Act. March 2018. URL:https://www.fda.gov/science‐research/pediatrics/best‐pharmaceuticals‐children‐act‐and‐pediatric‐research‐equity‐act.

5. Public law 108–155—Dec. 3 2003. Pediatric research equity act. December 2003. URL:https://www.congress.gov/108/plaws/publ155/PLAW‐108publ155.pdf.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of non-systemic juvenile idiopathic arthritis;Nature Reviews Rheumatology;2024-02-06

2. The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA;Pediatric Rheumatology;2024-01-05

3. Artritis idiopática juvenil: una enfermedad limitante;Salud, Ciencia y Tecnología;2023-10-15

4. Juvenile Idiopathic Arthritis;Pediatrics in Review;2023-10-01

5. Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design;Arthritis & Rheumatology;2023-08-03